Compare Humana Inc (HUM) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs NIO Inc. — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while NIO Inc. trades at $3.46 (market cap $8.67B). The key difference: Humana Inc is far larger — about 5.5× NIO Inc.'s market cap, and Humana Inc pays a 0.89% dividend while NIO Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and NIO Inc. for 81 Days on average.
| HUM | NIO | |
|---|---|---|
Market Cap | $47.61B | $8.67B |
Volume | 1,827,332 | 25,622,800 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $7.46 |
52-Week Low | $163.67 | $3.37 |
Typical Hold Time | 53 Days | 81 Days |
Enterprise Value | $54.97B | $6.57B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
NIO trades at $3.41, down 2.01% today and near its 52-week low of $3.38. The stock shows bearish technical signals with negative moving averages, though oscillators are neutral. Fundamentally, revenue grew to $87.49B in 2025 with improving net margin to -17.8%, but the company remains unprofitable with negative ROE of -332.77%. Recent news highlights a strategic battery-swap partnership with Geely, valued at $2.38B, which could expand NIO's charging network reach.
The outlook remains challenging amid a brutal EV price war in China, though analyst consensus is bullish with a $6.23 price target implying 83% upside. Key risks include persistent losses, high debt, and intense competition. Institutional sentiment is mixed with 50% buy ratings, but the stock's current valuation at 0.51 P/S may attract value investors betting on a long-term turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
